chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My left arm has been sore every since vaccine.  Can't lay on that side or let it touch anything. Headache and aches at bedtime Friday night, breathing problems at 3 a.m. the next morning. Felt like bus ran over me Saturday morning. Saturday afternoon better. Saturday night around 10 p.m. my left armpit felt like there were razorblades underneath. Aches and headache at night. Sunday armpit still hurt.  Monday morning as I write this still hurts.
Patient had COVID on 25Jan2022; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Patient had COVID on 25Jan2022) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019A21A and 038A21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Flu shot (Give within one month prior to modernaCovid-19 Vaccine). Past adverse reactions to the above products included No adverse event with Flu shot.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Jan-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (Patient had COVID on 25Jan2022). At the time of the report, COVID-19 (Patient had COVID on 25Jan2022) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2022, SARS-CoV-2 test: positive (Positive) Positive.         No concomitant medication reported. No treatment medications were provided by reporter.  Company comment: This spontaneous case concerns 55-years-old, female patient with no reported medical history, who experienced the unexpected nonserious  event of COVID-19 which occurred 3 months 24 days after the third dose of mRNA-1273 vaccine.  SARS-CoV-2 test was positive as on 25-Jan-2021. No medical assessment or treatment has been informed. Ongoing pandemic remains a confounder. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-557009 (Patient Link).; Sender's Comments: This spontaneous case concerns 55-years-old, female patient with no reported medical history, who experienced the unexpected nonserious event of COVID-19 which occurred 3 months 24 days after the third dose of mRNA-1273 vaccine.  SARS-CoV-2 test was positive as on 25-Jan-2021. No medical assessment or treatment has been informed. Ongoing pandemic remains a confounder. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.
Mom reported to the school nurse on 12/6/01, that the pt was complaining that "his leg (R) hurt and he couldn't move it easy". Mom reported later to the physician that "when he awoke, he really couldn't move his (R) leg". He no more symptoms after 48 hours.
I broke out in hives everywhere on my body , it first began only on thighs and arms then spread everywhere , benedryl couldn't help i needed to get on steroids
This spontaneous report was received from a nurse practitioner and refers to a patient of unknown age and gender. On 24-NOV-2015 the patient was vaccinated with first dose of (Oka/Merck) VARIVAX lot # L015045 which was improperly stored. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
on the evening of the vaccination , had the expected effects, such as fever, muscle pains, stomach ache, nausea, headache, ..the nest day, my legs were so sore that I could barely stand & I had to wait for. while until I could walk. the headache lasted for a few days, the muscle pain is lessening but not gone until today, it makes my legs & feet grow sore & tired very quickly. last Sunday, April 18 2021, started around 5 pm, I started having nausea , then stomach pain so bad & vomitted many times until I was admitted to ER around midnight . the med staff at the ER  did X-ray & citi scan, told me there was some bowel obstruction , gave me ivy, painkiller injection & some others then I was transferred to a medical center. they did another citi scan & found everything was ok, I asked what may cause it, they didn't really know beside probably not enough water etc .
Patient vaccinated with J&J on 4/12/21 and 11/5/21. Presented to ED for worsening symptoms of COVID on 1/10/22. Patient was unable to work and had increasing shortness of breath and muscle weakness. Patient was stable enough for discharge, and sent home with supportive care.
The pt experienced local erythema around the injection site, no induration, warmth, or tenderness.
Several episodes of heart paid beginning 5/24/21, around 2 weeks after my second dose.  I have had several visits to urgent care and now am seeing a cardiologist on 12/20/21 for further investigation.  I have suspected myocarditis.
sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: VITAMIN B12 [CYANOCOBALAMIN]. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm". Additional information: It was asked if it's okay to take the patient's monthly shot of vit b-12 or should she wait before taking it.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Myalgia, Arthralgia, injection site redness, pain. Chills and fatigue,  Narrative:
NO LOC , CLIENT FELT DIZZY AFTER  SHOT, HAS A HISTORY OF PASSING OUT/DIZZINESS AFTER INJECTION OR BLOOD DRAWS, NO DISTRESS, VS WNL, EVALUATED, RELEASED
Continued pain at site of injection and through upper arm  even 8 months after receiving first booster
Fever - 12-16 hours symptoms lasted severe body aches severe headache. TYLENOL & Ibuprofen.
Patient stated after 1st dose she had tingly lips, but took benadryl and was fine. Gave patient her second moderna dose, she purchased and took benadryl immediately after and sat in the waiting room. We told her to wait 30 minutes . I checked on her after 15 minutes  and she said she felt fine. At about 20 minutes into her waiting she started grabbing at her throat and saying she was having trouble swallowing, and that her tongue felt numb. I called 911 and the other pharmacist sat with her and checked her blood pressure (which was very elevated). EMS arrived and transported her to the hospital. She was talking, breathing, sitting up alert and awake when EMS arrived.
Pneumovax 23 was given in error. Prevnar 13 was supposed to be given. No immediate adverse effects were noted. I contacted mom the day after the shot was given and he slept a little later in the morning than usual but otherwise was ok.
This spontaneous report was received from a Medical assistant refers to a patient of unknown demography. On 20-NOV-2013, the patient was vaccinated with the first dose of GARDASIL (dose, route and frequency were not reported). On 23-DEC-2013, the patient was vaccinated with the second dose of GARDASIL (dose, route and frequency were not reported). No adverse effects reported. No further information provided. Additional information has been requested.
pt recv vax & felt OK this AM 16APR97 started feeling dizzy @ 10AM;felt like had temp felt hot;lt shoulder tight sore, h/a, warmness @ site;t100.7 x 1;knot @ site w/o redness;pt did not go to work;pt exp flu synd & soreness @ inj site w/red
1. Numbness in left scapula area from 6/6/2021 early morning, still numbness from time to time till now (7/13/2021) 2. Low temperature fever.  Lasted 1.5 days.
During both my first and second Shingrix vaccination, I had all the listed side effects...and one not listed; very sore and sensitive teeth. Not life threatening or requiring anything more than several Ibuprofens, but something I thought I should report.
L-shoulder and R-shoulder joints extremely painful at rest (2/10 constant, dull ache) and worse on movement/exercise (8/10 sharp, stabbing pain) for 3 weeks following the vaccination. Also for 3 weeks, bilateral knee pain, (2/10 constant ache and 7/10 with any walking or movement). R-knee physically swollen with bursa bulging from underneath R-patella and ROM limited to 90 degrees ending in extreme pain and very uncomfortable pressure inside the R-knee joint. Pain/stiffness necessitated cessation of all normal physical exercise and training for 2 1/2 weeks. Able to continue work as procedures RN with maximum dosage, constant use of ibuprofen and acetaminophen.
LIVER FUNCTION TEST ABNORMAL. Information has been received from a physician concerning a 49 year old male with medical history of no known allergies, hypopituitarism, osteopenia, and a hip fracture who between February 2003 and August 2003 was vaccinated with a first, second and third dose of hepatitis B virus vaccine rHBsAg (yeast) (manufacturer unknown), respectively. Concomitant therapy included levothyroxin Na (LEVOTHROD), somatropin (growth horomone), testosterone injection (therapy unspecified), alendronate sodium (MSD) 70 mg not consistently taken every week (WAES 0310USA02073) and atovastatin calcium (LIPITOR) (discontinued). In August 2003, after the third dose, the patient developed an increase in LFT's. It was noted that the patient "felt well" throughout the LFT elevations. Prescription drug treatment was not required. laboratory diagnostic tests performed in August, 2003 were "alkPhos" 351, "AST"257; "ALT" 587; "GGTP"2099 and "tbili" 0.7. On 08-Oct-2003, laboratory tests were "Alkphos" 99; "AST" 32; "ALT" 43 and "tbili" 0.4. Laboratory diagnostic studies performed were MRI, CT scan and an ultrasound (results not reported). Subsequently, the patient recovered. Medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
complaints of shortness of breath , coughing and bodyches for 6 days now, positive for covid, brought in via EMS.
No addittional adverse effects reported; MMR II that underwent temperature excursions was administered; This spontaneous report was received from a reporter, referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions, or allergies were not reported.  On 12-OCT-2021, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection (strength, vaccination scheme, anatomical site of vaccination and route of administration were not reported; lot number T033814, expiration date reported and validated as 05-OCT-2022) as prophylaxis, that underwent a temperature excursion (product storage error). No additional adverse effect reported.  The vaccine experienced temperature excursions above 9 degrees Celsius (C) (12.4C) for 53 minutes and 0 seconds, above 9C (9.6C) for 34 minutes and 0 seconds, above 9C (9.5C) for 23 minutes and 0 seconds and above 9C (8.5C) for 9 minutes and 0 seconds. There was no previous temperature excursion.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2112USA006870:
losing her hair,almost completely lost all her hair,still loosing her hair; it is a little depressing; it spread down to lymph nodes and breast and across shoulder; arm was very sore for days; it spread down to lymph nodes and breast and across shoulder; tired; it spread down to lymph nodes and breast and across shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (losing her hair,almost completely lost all her hair,still loosing her hair) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Knee replacement in March 2020. Concomitant products included ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]) from 2021 to an unknown date and SUCRALFATE (CARAFATE) from 2021 to an unknown date for Peptic ulcer.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ALOPECIA (losing her hair,almost completely lost all her hair,still loosing her hair) (seriousness criterion medically significant), DEPRESSION (it is a little depressing), BREAST PAIN (it spread down to lymph nodes and breast and across shoulder), MYALGIA (arm was very sore for days), LYMPH NODE PAIN (it spread down to lymph nodes and breast and across shoulder), FATIGUE (tired) and ARTHRALGIA (it spread down to lymph nodes and breast and across shoulder). The patient was treated with CORTISONE ACETATE ongoing since an unknown date for Alopecia, at an unspecified dose and frequency. At the time of the report, ALOPECIA (losing her hair,almost completely lost all her hair,still loosing her hair) had not resolved, DEPRESSION (it is a little depressing) outcome was unknown and BREAST PAIN (it spread down to lymph nodes and breast and across shoulder), MYALGIA (arm was very sore for days), LYMPH NODE PAIN (it spread down to lymph nodes and breast and across shoulder), FATIGUE (tired) and ARTHRALGIA (it spread down to lymph nodes and breast and across shoulder) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case concerns a 66-year-old, female patient with no relevant medical history, who experienced the unexpected event of Alopecia. The events occurred a couple of weeks after the second dose. The rechallenge is not applicable. The benefit-risk relationship of Spikevax in not affected by this report.; Sender's Comments: This case concerns a 66-year-old, female patient with no relevant medical history, who experienced the unexpected event of Alopecia. The events occurred a couple of weeks after the second dose. The rechallenge is not applicable. The benefit-risk relationship of Spikevax in not affected by this report.
Several days after 2nd dose of Pfizer I started experience increased pain in my jaw as well as my right thumb. I do have TMJ though it is controlled/mild and haven?t had issues with it in a few years. After 2nd dose experience pain and discomfort throughout the day.    I have also been experiencing increased pain and discomfort in my right thumb where I believe I have some signs of arthritis since receiving the 2nd dose.
first dose of Shingrix on 2019 and has not received the second dose yet; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of no adverse event (1st dose received on unknown date in 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led incomplete course of vaccination. The reporter consented to follow up.
Patient is planning on getting the second dose of the vaccine more than 42 days after the first dose (time deviation); This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient is planning on getting the second dose of the vaccine more than 42 days after the first dose (time deviation)) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jul-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient is planning on getting the second dose of the vaccine more than 42 days after the first dose (time deviation)). On 01-Jul-2021, PRODUCT DOSE OMISSION ISSUE (Patient is planning on getting the second dose of the vaccine more than 42 days after the first dose (time deviation)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications were unknown.   Reporter did not allow further contact
This spontaneous report was received from a medical assistant, concerning an unspecified number of patients of an unknown age and gender. The patients' medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On an unspecified date, the patients were vaccinated with improperly stored doses of ROTATEQ from lot # M040268 with expiration date on 14-MAY-2018, and also the lot # M038846 with expiration date on 26-APR-2018 (strength and dose were not reported), taken orally for prophylaxis. The storage temperature was reported as 32 to 35 degrees Fahrenheit (°F) (34 °F) for a time frame of 30 minutes. There was no previous temperature excursion. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1705USA010492: US-009507513-1705USA010490: US-009507513-1705USA010491: US-009507513-1705USA010488: US-009507513-1705USA006600:
Pfizer vaccine lot #FK9729 was affected due to out of temperature range. No adverse reactions from patients.  3 patient's affected.
This case was reported by a healthcare professional and described the occurrence of splashed injectable drug in eye in an adult female subject who was vaccinated with TWINRIX (GlaxoSmithKline).  On 12 June 2008 at 12:00, the subject received an unspecified dose of TWINRIX (intraocular, unknown).  A healthcare professional reported the needle came off of the syringe while a nurse was administering a TWINRIX injection, and the nurse was accidentally sprayed in the face and the eye with the solution.  The affected areas were washed and flushed with water.  No irritation was reported.  It was unknown at the time of this report if the nurse was sent for further medical attention.  No adverse events were reported.  The healthcare professional considered the events were clinically significant (or requiring intervention), and were probably related to the use of TWINRIX.  At the time of reporting, the outcome of the events was unspecified.
Fully vaccinated with booster on 11/23/21.   Breakthrough COVID infection 11/26 and inpatient hospital stay 12/2/21  Vaccine 1 Lot #   1805022 Vaccine 2 Lot #     939909
UPON RECEIVING  THE MODERNA VACCINE PT COLLAPSED, HIT THE FLOOR  WITH LESS THAN 2-3 MINUTES AND THEN REGAINED CONSCIOUSNESS ; PT STATED SHE FELT DIZZY; BP 141/85 PULSE 95
The interval duration between vaccines was not adequate time  9/25/20     11/05/20   and  1/26/21    The short duration between vaccine 2 and 3 will not mount the immune response that is needed for the vaccine to have full effect. Per recommendation by Merck the pt will need to obtain a 4th vaccine
Information has been received from a health care professional via Pfizer (MFR control# 2016538484) referring to a currently 64 year old female patient. Information about concurrent condition, medical history and concomitant medication was unspecified. On an unknown date the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (manufacturer unknown) (dose, lot#, expiration date and route unknown) for prophylaxis. On an unknown date the patient had allergy to varicella virus vaccine live (oka/merck) (manufacturer unknown) and experienced unspecified contraindication. The outcome of the events was unknown. The reporter considered the events to be related to varicella virus vaccine live (oka/merck) (manufacturer unknown). The patient also had allergy to pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) and experienced fever (captured in MARRS# 1612USA004206). Additional information has been requested. Sender's Comments: US-009507513-1612USA004206.
AT APPROXIMATELY 6:00PM, CHILD STARTED CRYING STATING HIS ARM HURT, HAD A HEADACHE, FELT LIGHTHEADED, NAUSEOUS. FELT "HOT". TYLENOL GIVEN PER MOM. CHILD STARTED TO FEEL BETTER. WENT TO SLEEP. APPROXIMATELY 3:30 AM, ARM HURT AGAIN, NAUSEOUS, LIGHTHEADED, TEMP 100.3. TYLENOL GIVEN. VOMITED A FEW MINUTES LATER. BACK TO SLEEP. AT 9:00AM, PATIENT C/O PAIN AND HEAD HURTS. LEGS ALSO HURT. MOTRIN GIVEN BY MOM AT 10:30AM. MOM SPOKE WITH PRIMARY CARE PROVIDER WHO ASSURED HER THIS WAS A NORMAL REACTION TO THE VACCINE. AT 2:30PM 8-14-15 MOM CONTACTED HD TO NOTIFY STAFF OF REACTION. CHILD FEELS OKAY.
was vaccinated but still got them/suspected vaccination failure; was vaccinated but still got them; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by the patient. The age at vaccination was not reported. The patient was vaccinated but still got them (shingles). This case was considered as suspected vaccination failure as details regarding primary vaccination schedule, time to onset and laboratory confirmation were unknown at the time of reporting. The follow up would not be possible as no contact details were available.
TOOK TWO DOSES IN A ROW; This spontaneous case report (PVX2019-1960) was received from a nurse on 29-Jul-2019. It described a 79-year-old elderly female consumer who "took two doses in a row" (PT: Inappropriate schedule of product administration), while being on Vivotif for an unknown indication.  Case report: The consumer took second and the third dose of Vivotif in a row. The doses were taken on 26-Jul-2019, 28-Jul-2019, and 29-Jul-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.
Tremors about 10PM 12APR; @ 2AM 15APR screaming trembling; Sz @ 230PM; Took to ER in ambulance;
15MAY91 had t103x 3 days; Lt leg had raised, red area, 3" wide & 2" long;